Company / Assets per Share
Idexx Laboratories Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$41.06
FY2025
5-year range
$28.52 / $41.06
FY2021-FY2025
Trend
+3.5%
vs FY2024
Sector context
#75 of 163
Health Care
What the data says
At $41.06, Idexx Laboratories's assets per share ranks #75 of 163 in the Health Care sector. Assets per Share has increased for 7 consecutive years, from $17.65 in FY2018 to $41.06 in FY2025.
Based on SEC 10-K filings.
41.06 in FY2025 with a 5-year CAGR of +8.9%.
Improved from $39.33 to $41.06 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +8.1%
- 5-Year CAGR
- +8.9%
- 10-Year CAGR
- -
Sector benchmark
#75 of 163 in Health CareTop 46% of 163This company $41.06 Sector average $114.70
▼
-64.2% below sector average
Key checks
Key Insights
- Idexx Laboratories's assets per share has grown for 7 consecutive years.
- In FY2025, assets per share increased 3.5% year-over-year.
- Ranks #75 out of 163 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $41.06 | +3.5% |
| FY2024 | $39.66 | +0.9% |
| FY2023 | $39.33 | +21.1% |
| FY2022 | $32.48 | +13.9% |
| FY2021 | $28.52 | +6.2% |
| FY2020 | $26.85 | +26.1% |
| FY2019 | $21.28 | +20.6% |
| FY2018 | $17.65 | -3.5% |
| FY2017 | $18.30 | +21.3% |
| FY2016 | $15.08 | +10.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026